Announcements Trials

Browse Landscape

Phase

Phase 2/3 2 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 10 Neoplasms 4 Neoplasm Metastasis 3 Lung Neoplasms 2 Gastrointestinal Neoplasms 2 Colorectal Neoplasms 2 Breast Neoplasms 2 Urinary Bladder Neoplasms 1 Thyroid Neoplasms 1 Thyroid Cancer, Papillary 1 Thoracic Neoplasms 1 Solid Tumors 1 Sarcoma 1 Salivary Gland Neoplasms 1 Respiratory Tract Neoplasms 1 Respiratory Tract Diseases 1 Rare Tumour 1 Rare Tumor 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neuroendocrine Tumors 1 Neoplasms, Unknown Primary 1 Neoplasms by Site 1 Melanoma 1 Lymphoma, Large-Cell, Anaplastic 1 Intestinal Neoplasms 1 Intestinal Diseases 1 Hematologic Neoplasms 1 Head and Neck Neoplasms 1 Genomic Instability 1

Interventions

Cyclophosphamide 41 fludarabine 35 Tacrolimus 28 Mycophenolic Acid 27 Whole-Body Irradiation 25 Busulfan 24 fludarabine phosphate 21 Melphalan 19 thymoglobulin 16 Antilymphocyte Serum 16 Methotrexate 13 Thiotepa 12 Stem Cell Transplantation 9 Rituximab 9 Granulocyte Colony-Stimulating Factor 9 Filgrastim 8 Cyclosporine 8 trametinib 7 Sirolimus 7 Nivolumab 5 ruxolitinib 4 merphos 4 Peripheral Blood Stem Cell Transplantation 4 Cytarabine 4 Cord Blood Stem Cell Transplantation 4 Bendamustine Hydrochloride 4 tocilizumab 3 itacitinib 3 fedratinib 3 dabrafenib 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Hematologic Neoplasms × alectinib × Clear all

NCT05159245 2024-07-15

FINPROVE

Helsinki University Central Hospital

Phase 2 Recruiting

Other hematologic neoplasm

Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡